These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Peters DH, Friedel HA, McTavish D. Drugs; 1992 Nov; 44(5):750-99. PubMed ID: 1280567 [Abstract] [Full Text] [Related]
6. Azithromycin and clarithromycin: overview and comparison with erythromycin. Whitman MS, Tunkel AR. Infect Control Hosp Epidemiol; 1992 Jun; 13(6):357-68. PubMed ID: 1320067 [Abstract] [Full Text] [Related]
8. Lack of emergence of significant resistance in vitro and in vivo to the new azalide antibiotic azithromycin. Retsema JA, Girard AE, Brennan LA, Cimochowski CR, Faiella JA. Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):843-6. PubMed ID: 1662628 [Abstract] [Full Text] [Related]
17. Azithromycin: the first azalide antibiotic. Ballow CH, Amsden GW. Ann Pharmacother; 1992 Oct; 26(10):1253-61. PubMed ID: 1330097 [Abstract] [Full Text] [Related]
18. Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy in vivo. Retsema JA, Girard AE, Girard D, Milisen WB. J Antimicrob Chemother; 1990 Jan; 25 Suppl A():83-9. PubMed ID: 2154442 [Abstract] [Full Text] [Related]
19. Azithromycin--spectrum of activity, pharmacokinetics, and clinical applications. Drew RH, Gallis HA. Pharmacotherapy; 1992 Jan; 12(3):161-73. PubMed ID: 1319048 [Abstract] [Full Text] [Related]
20. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Retsema J, Girard A, Schelkly W, Manousos M, Anderson M, Bright G, Borovoy R, Brennan L, Mason R. Antimicrob Agents Chemother; 1987 Dec; 31(12):1939-47. PubMed ID: 2449865 [Abstract] [Full Text] [Related] Page: [Next] [New Search]